You are here

News

subscribe

The latest international news, analysis and features on the HIV epidemic from AVERT. Share your views and expertise with your peers in the comments box below the articles.

16 February 2018

People in poorer countries in Latin America and the Caribbean adhere better to HIV treatment

New study provides insights into the factors that influence treatment adherence in Latin America and the Caribbean. Results show that individuals from lower resource settings often achieve higher levels of adherence, contrary to predictions. 

0
05 February 2018

New data helps prioritise groups for HIV treatment in low resourced settings

Lancet study reveals for the first time who can benefit most from immediate antiretroviral treatment – enabling prioritisation in low-resourced settings. But who is left behind?

0
17 November 2017

Immediate HIV treatment drastically reduces mortality in China

Immediate antiretroviral treatment (ART) for people with low CD4 counts in China reduces overall mortality by 63% – confirming trials in other countries that have shown the benefit of early treatment for improved health outcomes.

0
02 October 2017

Breakthrough as single-dose HIV treatment deal announced

Agreement ushers in first single-dose, affordable HIV treatment for low- and middle-income countries.

0
21 August 2017

Better patient communication gets more people admitting adherence issues

A pilot that saw health workers adopt ‘patient-centred’ communication at an HIV clinic in rural Tanzania led to a three-fold increase in the number of people openly reporting treatment adherence problems.

0
03 August 2017

Injectable antiretroviral drugs – a ‘remarkable milestone’

Long-lasting antiretroviral drugs injected monthly present a ‘remarkable milestone’ in treatment options for people living with HIV

0
20 July 2017

HIV drug resistance is rising and needs urgent attention, says World Health Organization

Without urgent action, HIV drug resistance is set to derail the HIV response and presents a significant threat to public health, the World Health Organization (WHO) warns today.

0
28 June 2017

HIV wonder drug dolutegravir to be rolled-out in Kenya

UNITAID partners to bring newer and more effective HIV treatment options to countries where they are needed most.

0
22 June 2017

PrEP now included on the WHO Essential Medicines List

Key HIV drugs added to the list of medicines critical to public health, including tenofovir for HIV prevention, and dolutegravir.

0
03 May 2017

India to provide free treatment for all people living with HIV

The country with the third largest HIV epidemic moves to a test-and-treat strategy that aims to get everyone on antiretroviral therapy.

0